11 Dec 2019
Stephen Chipman, former chief executive of Grant Thornton US, also takes a seat on the board
Want to learn more about CRISPR's IP licensing landscape?
The IPM team, alongside Scrip colleagues and genomics and legal experts, discuss the impact of the revolutionary gene editing technology CRISPR. In this webinar, our panellists will address how CRISPR represents a true revolution in the life sciences sector and how it can be applied to a wide range of industries including human therapeutics, animal health, agriculture and the bioindustry.
Listeners will learn:
03 Dec 2019
Jean Boustani, a salesman for Privinvest, an Abu Dhabi-based shipbuilder, was acquitted of three counts of conspiracy to commit fraud...